Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK-801

Developmental Brain Research

Volumn 122, Issue 1, 2000, Pages 91-95

  Jacobs, Pamela S ^a   Taylor, Benjamin M ^a   Bardgett, Mark E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c Fos; Development; Dizocilpine; Immediate early gene; Locomotion; Motor cortex; Phencyclidine; Posterior retrosplenial cortex; Schizophrenia

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DRUG SENSITIVITY; LOCOMOTION; MALE; MOTOR CORTEX; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGE FACTORS; ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GENES, IMMEDIATE-EARLY; GYRUS CINGULI; LOCOMOTION; MALE; MOTOR CORTEX; PHENCYCLIDINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SEXUAL MATURATION;

ANIMALIA;

EID: 0034734128     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(00)00059-6     Document Type: Article

References (18)

1. Bardgett M.E., Henry J.D. Locomotor activity and accumbens fos expression driven by hippocampal stimulation requires D1 and D2 receptors. Neuroscience. 94:1999;59-70.
2. Bardgett M.E., Jackson J.L., Taylor B.M., Csernansky J.G. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine. Psychopharmacology. 135:1998;270-278.
3. Bardgett M.E., Jacobs P.S., Jackson J.L., Csernansky J.G. Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801. Behav. Brain Res. 84:1997;47-55.
4. 3H)MK-801 binding to N-methyl-D-aspartate receptor-coupled ion channels. Dev. Brain Res. 65:1992;51-56.
5. Brenner D.M., Bardgett M.E. Haloperidol blocks increased locomotor activity elicited by carbachol infusion into the ventral hippocampal formation. Pharmacol. Biochem. Behav. 60:1998;759-764.
6. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
7. Farber N.B., Wozniak D.F., Price M.T., Labruyere J., Huss J., St. Peter H., Olney J.W. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol. Psychiatry. 38:1995;788-796.
8. 14C)-2-deoxyglucose autoradiographic study. J. Neurosci. 17:1997;4415-4425.
9. Hamon B., Heinemann U. Developmental changes in neuronal sensitivity to excitatory amino acids in area CA1 of the rat hippocampus. Dev. Brain Res. 38:1988;286-290.
10. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T., Stegovska V., Turski L. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:1999;70-74.
11. Izumi Y., Clifford D.B., Zorumski C.F. Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science. 257:1992;1273-1276.
12. Laurie D.J., Seeburg P.H. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J. Neurosci. 14:1994;3180-3194.
13. Mattson M.P., Wang H., Michaelis E.K. Developmental expression, compartmentalization, and possible role in excitotoxicity of a putative NMDA receptor protein in cultured hippocampal neurons. Brain. Res. 565:1991;94-108.
14. Ojeda S.R. The mystery of mammalian puberty: How much more do we know? Perspect. Biol. Med. 34:1991;365-383.
15. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry. 52:1995;998-1007.
16. Parthasarathy H.B., Graybiel A.M. Cortically driven immediate early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J. Neurosci. 17:1997;2477-2491.
17. Roe D.L., Bardgett M.E., Csernansky C.A., Csernansky J.G. Induction of fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss. Psychopharmacology. 138:1998;151-158.
18. Scalzo F.M., Burge L.G. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Neurotoxicity. 15:1994;191-200.